Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Deficiency Syndromes | 4 | 2017 | 547 | 0.950 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 169 | 0.540 |
Why?
|
| Common Variable Immunodeficiency | 2 | 2018 | 93 | 0.520 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 476 | 0.480 |
Why?
|
| Anti-Allergic Agents | 2 | 2012 | 141 | 0.440 |
Why?
|
| Antibody Affinity | 1 | 2013 | 254 | 0.420 |
Why?
|
| Mastocytosis | 1 | 2013 | 160 | 0.400 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2011 | 56 | 0.380 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 349 | 0.340 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 391 | 0.340 |
Why?
|
| Pneumococcal Infections | 1 | 2013 | 497 | 0.320 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2010 | 337 | 0.310 |
Why?
|
| Case Management | 1 | 2009 | 286 | 0.300 |
Why?
|
| Antibodies, Bacterial | 1 | 2013 | 1470 | 0.290 |
Why?
|
| Histocompatibility Antigens | 2 | 2005 | 471 | 0.250 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2005 | 279 | 0.230 |
Why?
|
| Virus Diseases | 1 | 2009 | 711 | 0.220 |
Why?
|
| Immunotherapy | 1 | 2017 | 4445 | 0.200 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1580 | 0.200 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2014 | 168 | 0.190 |
Why?
|
| Bacterial Infections | 1 | 2009 | 1401 | 0.190 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5442 | 0.170 |
Why?
|
| Mast Cells | 2 | 2019 | 1544 | 0.170 |
Why?
|
| Cell Degranulation | 1 | 2019 | 287 | 0.160 |
Why?
|
| Tryptases | 1 | 2019 | 190 | 0.160 |
Why?
|
| Epidermodysplasia Verruciformis | 1 | 2017 | 16 | 0.150 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2018 | 212 | 0.150 |
Why?
|
| Ectodermal Dysplasia | 1 | 2016 | 106 | 0.130 |
Why?
|
| Graft Survival | 2 | 2005 | 3737 | 0.130 |
Why?
|
| Lymphopenia | 1 | 2017 | 285 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2016 | 252 | 0.130 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2014 | 59 | 0.130 |
Why?
|
| Heart Transplantation | 2 | 2005 | 3110 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 873 | 0.120 |
Why?
|
| Sucrose | 1 | 2014 | 164 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 581 | 0.110 |
Why?
|
| Pregnenediones | 1 | 2012 | 29 | 0.110 |
Why?
|
| Carbohydrates | 1 | 2014 | 394 | 0.100 |
Why?
|
| Lymphocyte Activation | 2 | 2018 | 5524 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2005 | 4397 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1152 | 0.100 |
Why?
|
| B-Lymphocytes | 2 | 2018 | 4665 | 0.100 |
Why?
|
| Drug Hypersensitivity | 1 | 2020 | 884 | 0.100 |
Why?
|
| Eosinophils | 2 | 2014 | 955 | 0.100 |
Why?
|
| Agammaglobulinemia | 1 | 2012 | 167 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 570 | 0.100 |
Why?
|
| Pancytopenia | 1 | 2011 | 104 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 10180 | 0.090 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2013 | 578 | 0.090 |
Why?
|
| Ikaros Transcription Factor | 1 | 2011 | 217 | 0.090 |
Why?
|
| Introns | 1 | 2012 | 991 | 0.090 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2009 | 87 | 0.080 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2011 | 223 | 0.080 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 598 | 0.080 |
Why?
|
| Amino Acids | 1 | 2014 | 1736 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2011 | 23403 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1378 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 2849 | 0.070 |
Why?
|
| Granuloma | 1 | 2009 | 319 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 2916 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2014 | 2017 | 0.070 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2011 | 587 | 0.070 |
Why?
|
| Rats, Inbred Lew | 2 | 2005 | 1162 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2017 | 3023 | 0.070 |
Why?
|
| Point Mutation | 1 | 2011 | 1623 | 0.070 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 419 | 0.060 |
Why?
|
| Cell Separation | 1 | 2011 | 1751 | 0.060 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3597 | 0.060 |
Why?
|
| Transfection | 2 | 2011 | 5892 | 0.060 |
Why?
|
| Child | 6 | 2019 | 77709 | 0.060 |
Why?
|
| Sarcoidosis | 1 | 2009 | 506 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 893 | 0.060 |
Why?
|
| Solubility | 1 | 2005 | 1085 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2915 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2017 | 1850 | 0.050 |
Why?
|
| Biopsy | 1 | 2013 | 6756 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
| Antibodies | 1 | 2009 | 2460 | 0.050 |
Why?
|
| Humans | 17 | 2023 | 744343 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 4386 | 0.050 |
Why?
|
| Protein Binding | 1 | 2013 | 9386 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7880 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3690 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2011 | 5974 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9648 | 0.040 |
Why?
|
| Infant | 4 | 2019 | 35136 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2019 | 41006 | 0.040 |
Why?
|
| Mutation | 2 | 2016 | 29786 | 0.040 |
Why?
|
| Cyclosporine | 1 | 2001 | 786 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 13815 | 0.040 |
Why?
|
| Urticaria | 1 | 2019 | 150 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 18111 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2018 | 246 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 708 | 0.040 |
Why?
|
| Disease Progression | 1 | 2013 | 13284 | 0.040 |
Why?
|
| Transplantation Tolerance | 1 | 2001 | 617 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 3772 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2009 | 2303 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2017 | 281 | 0.030 |
Why?
|
| Desensitization, Immunologic | 1 | 2020 | 483 | 0.030 |
Why?
|
| Pediatrics | 1 | 2010 | 3475 | 0.030 |
Why?
|
| Consanguinity | 1 | 2017 | 454 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1366 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 2016 | 399 | 0.030 |
Why?
|
| Animals | 5 | 2017 | 168757 | 0.030 |
Why?
|
| Budesonide | 1 | 2014 | 154 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2018 | 1465 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 1785 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 390 | 0.030 |
Why?
|
| Quality of Life | 1 | 2013 | 12804 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2001 | 2240 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 2019 | 746 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 85781 | 0.030 |
Why?
|
| Asthma | 1 | 2010 | 6011 | 0.030 |
Why?
|
| src Homology Domains | 1 | 2012 | 364 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2005 | 4479 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 1836 | 0.020 |
Why?
|
| Rats | 2 | 2005 | 24260 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 7181 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2011 | 133 | 0.020 |
Why?
|
| Male | 8 | 2019 | 350118 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1856 | 0.020 |
Why?
|
| Exons | 1 | 2016 | 2437 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2499 | 0.020 |
Why?
|
| Inflammation | 1 | 2009 | 10638 | 0.020 |
Why?
|
| Female | 7 | 2019 | 380194 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2011 | 585 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4149 | 0.020 |
Why?
|
| Pedigree | 1 | 2016 | 4644 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 652 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2011 | 1588 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 4560 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 18029 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1791 | 0.020 |
Why?
|
| Mothers | 1 | 2016 | 2165 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 25625 | 0.010 |
Why?
|
| Hospitalization | 1 | 2023 | 10262 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10481 | 0.010 |
Why?
|
| Gestational Age | 1 | 2011 | 3493 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12745 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77449 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2011 | 2948 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2023 | 40561 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 21746 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 2001 | 2186 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1855 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.010 |
Why?
|
| Isoantibodies | 1 | 2001 | 679 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2009 | 2958 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2001 | 1402 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2001 | 1267 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2011 | 14557 | 0.010 |
Why?
|
| Mice | 2 | 2012 | 81183 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 1821 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2001 | 3002 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6314 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 16365 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.010 |
Why?
|
| Myocardium | 1 | 2001 | 4776 | 0.010 |
Why?
|
| Apoptosis | 1 | 2001 | 9727 | 0.000 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_